What is TG Therapeutics's debt issuance costs?

TG Therapeutics (TGTX) reported debt issuance costs of $2.6M in Q1 2026.

What does debt issuance costs mean?

Cash paid for fees associated with taking on new debt.

How do you interpret debt issuance costs?

Higher costs relative to issuance size may indicate less favorable borrowing terms or complex financing structures.

How does debt issuance costs compare across companies?

Standard for all companies that utilize debt financing.

TG Therapeutics TGTX Debt Issuance Costs

Debt Issuance Costs at other companies

Arrowhead ResearchARWR

$18.72M—

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfFinancingCosts.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's debt issuance costs?: TG Therapeutics (TGTX) reported debt issuance costs of $2.6M in Q1 2026.
What does debt issuance costs mean?: Cash paid for fees associated with taking on new debt.
How do you interpret debt issuance costs?: Higher costs relative to issuance size may indicate less favorable borrowing terms or complex financing structures.
How does debt issuance costs compare across companies?: Standard for all companies that utilize debt financing.